Evidence map›Paper›PMID 31371938›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2019

The relationship between acrolein and oxidative stress in COPD: in systemic plasma and in local lung tissue.

Masanori Yasuo, Yunden Droma, Yoshiaki Kitaguchi, Michiko Ito, Hitomi Imamura, Masatomo Kawakubo, Masayuki Hanaoka

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Origin and Fate of Acrolein in Foods.Foods (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Autophagy Induced by BCL2-Related ceRNA Network Participates in the Occurrence of COPD.International journal of chronic obstructive pulmonary disease · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Masanori YasuoThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Yunden DromaThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Yoshiaki KitaguchiThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Michiko ItoThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Hitomi ImamuraThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Masatomo KawakuboDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, Nagano, Japan.
Masayuki HanaokaThe First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Shinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Cigarette smoke produces a high level of acrolein, which is thought to be pathogenically involved in the development of chronic obstructive pulmonary disease (COPD). The present study investigated the pathological role of acrolein in the development of COPD. Patients and methods: Acrolein concentration was measured in plasmas obtained from 47 patients with COPD and 18 current smokers without COPD, and in supernatants of homogenized lung tissues obtained from 10 never-smokers, 8 current smokers, and 8 patients with COPD by high-performance liquid chromatography. Oxidant status and antioxidant activity were measured using derivatives of reactive oxygen metabolite (d-ROM) and bio-antioxidant power (BAP), respectively, in the Free Radical Elective Evaluation FRAS4 system. In addition, immunohistochemistry was used to evaluate the over-presentation of acrolein in lung tissues of patients with COPD. Results: Plasma concentrations of acrolein were significantly higher in the patients with COPD than the non-COPD smokers ( Conclusion: The increased acrolein concentrations were highly involved in the pathogenesis of COPD through interference in the balance of oxidative stress versus antioxidant potentiality.

Indexed as

Oxidative StressAcroleinAgedBiomarkersCase-Control StudiesFemaleHumansLungMaleNon-SmokersPulmonary Disease, Chronic ObstructiveSmokersSmokingAcroleinBiomarkersacroleinantioxidant potentiallung tissueoxidative stressplasmasmoke

Identifiers

PMID31371938
PMCPMC6636184
OpenAlexW2961730152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.